Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

409
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
409
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

68.0K
Overview
68.0K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

482
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
482
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

794
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
794
T Cell Types and Functions01:24

T Cell Types and Functions

996
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
996
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

977
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
977

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptation of the Transition Readiness Assessment Questionnaire for Pediatric-Onset Multiple Sclerosis: Protocol for a User-Centered Design Approach.

JMIR research protocols·2026
Same author

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Frontiers in immunology·2026
Same author

A Case of Persistent Ataxia and Atypical Brain Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

High-dose <i>N</i>-acetyl cysteine reduces GFAP levels: Exploratory results from a pilot double-blind, placebo-controlled randomized trial.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Focal Motor Seizures as a Manifestation of Rheumatoid Meningitis: From the National Multiple Sclerosis Society Case Conference Proceedings.

Neurology(R) neuroimmunology & neuroinflammation·2026

Related Experiment Video

Updated: Jun 21, 2025

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

81.9K

MOG CNS Autoimmunity and MOGAD.

Carson E Moseley1, Akash Virupakshaiah1, Thomas G Forsthuber1

  • 1From the Department of Neurology (C.E.M., A.V., E.W., S.S.Z.), Weill Institute for Neurosciences, University of California, San Francisco; Department of Molecular Microbiology and Immunology (T.G.F.), University of Texas at San Antonio; Department of Neurology and Neurological Science (L.S.), Stanford University; and Program in Immunology (S.S.Z.), University of California, San Francisco, CA.

Neurology(R) Neuroimmunology & Neuroinflammation
|July 12, 2024
PubMed
Summary

Myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD) is distinct from NMO and MS. While antibodies are involved, their exact role in central nervous system damage in MOGAD requires further investigation.

More Related Videos

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
10:47

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

Published on: October 27, 2016

11.0K
Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

2.1K

Related Experiment Videos

Last Updated: Jun 21, 2025

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

81.9K
Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
10:47

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

Published on: October 27, 2016

11.0K
Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

2.1K

Area of Science:

  • Neuroimmunology
  • Neurology

Background:

  • Myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD) was previously considered a neuromyelitis optica spectrum disorder (NMOSD).
  • MOGAD is now recognized as a distinct entity from NMOSD and multiple sclerosis (MS), presenting diverse clinical phenotypes.
  • While aquaporin-4 (AQP4) antibodies are pathogenic in NMO, the pathogenicity of anti-MOG antibodies in MOGAD remains under investigation.

Purpose of the Study:

  • To clarify the distinct nature of MOGAD from NMO and MS.
  • To investigate the pathogenic role of anti-MOG antibodies in central nervous system (CNS) damage within MOGAD.
  • To explore the immunological underpinnings of MOGAD, drawing parallels from MOG experimental autoimmune encephalomyelitis (EAE).

Main Methods:

  • Review of existing literature on MOGAD, NMO, and MS.
  • Analysis of immunological findings, including antibody isotypes (e.g., IgG1) and T cell involvement.
  • Comparison of MOGAD pathogenesis with insights from MOG experimental autoimmune encephalomyelitis (EAE) models.

Main Results:

  • MOGAD is a distinct neurological disorder with a spectrum of clinical presentations.
  • Anti-MOG antibodies, predominantly IgG1, are characteristic of MOGAD, similar to AQP4 antibodies in NMO.
  • MOG-specific T cells are crucial in MOG EAE, and while anti-MOG antibodies can worsen EAE, they are not solely causative.

Conclusions:

  • MOGAD represents a unique neuroinflammatory condition separate from NMO and MS.
  • Further research is needed to fully elucidate the contribution of anti-MOG antibodies to CNS pathology in MOGAD.
  • Understanding the humoral and cellular immunology of MOGAD is critical for improving diagnosis, treatment, and prognosis.